Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vista Pharmaceuticals has informed that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 29th Annual General Meeting of the Company with requisite majority. The Company had appointed NVSS Suryanarayana Rao, Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 27th September, 2021. In this connection, the company has enclosed the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio-Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizer’s Report. On the basis of the report received from the Scrutinizer, the Company has declared that the Resolutions set out in the notice of 29th AGM were passed with requisite majority in favour of the Resolutions.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1661.70 |
| Dr. Reddys Lab | 1223.70 |
| Cipla | 1235.95 |
| Zydus Lifesciences | 929.60 |
| Lupin | 2316.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: